FIELD: pharmaceuticals.
SUBSTANCE: invention relates to a DP receptor antagonist which is a compound of general formula (I), where R1, R2 -R6, R11, R12, L, J, m, n are defined in the claims, or a pharmaceutically acceptable salt thereof. The compounds are highly safe and can be used as active pharmaceutical ingredients in DP receptor mediated diseases.
EFFECT: compound represented by the general formula (I) and a pharmaceutically acceptable salt thereof also have a good ability to penetrate into the central nervous system, and thus are particularly useful as a prophylactic and/or therapeutic agent for diseases associated with DP receptors present in the central nervous system, in particular disturbances in sleep and wakefulness.
14 cl, 2 tbl, 22 ex
| Title | Year | Author | Number |
|---|---|---|---|
| CARBOXYLIC ACID COMPOUND AND MEDICAL COMPOSITIONS CONTAINING THEREOF AS ACTIVE INGREDIENT | 2004 |
|
RU2375353C2 |
| PHENYLACETIC ACID COMPOUNDS | 2008 |
|
RU2470926C2 |
| AGENT WHICH PREVENTS PREMATURE OVULATION | 2006 |
|
RU2419435C2 |
| PHOSPHORUS CONTAINING COMPOUNDS AS PROTEIN KINASE INHIBITORS | 2012 |
|
RU2598849C2 |
| NOVEL HYDROXY-ESTER DERIVATIVES, A METHOD FOR PRODUCTION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | 2016 |
|
RU2734418C2 |
| DERIVATIVES OF 6-AMINO QUINAZOLINE OR 3-CYANOQUINOLINE, METHODS OF THEIR PRODUCTION AND THEIR APPLICATION AS INHIBITORS OF RECEPTOR TYROZINE KINASES EGFR OR HER-2 | 2010 |
|
RU2536102C2 |
| MDM2 PROTEIN DESTRUCTORS | 2017 |
|
RU2743432C2 |
| ACTIVATOR OF KCNQ2-5 CHANNELS | 2015 |
|
RU2712163C2 |
| COMPOUND CAPABLE OF BONDING WITH S1P RECEPTOR AND PHARMACEUTICAL APPLICATION THEREOF | 2004 |
|
RU2390519C2 |
| ANTIHYPERTRIGLYCERIDEMIC COMPOSITION (VARIANTS), METHOD OF ITS PREPARING, METHOD OF TREATMENT OR PROPHYLAXIS OF HYPERTRIGLYCERIDEMIA | 1995 |
|
RU2166320C2 |
